3rd Quarter - Report

TEXAS MEDICAL ASSOCIATION for TEXAS MEDICAL ASSOCIATION

Firm
Client
Income
—
Expenses
$10,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

- Concerns regarding Calendar Year 2026 Medicare Physician Fee Schedule Proposal; CMS 1832-P which includes temporary relief, but no lasting solutions, and unsustainable cuts on top of eroding Medicare payments. - Urge Congress to enact legislation to extend the enhanced advance premium tax credits (APTCs) established under section 36B(b)(3)(A)(iii) of the Internal Revenue Code of 1986.Extending the enhanced APTCs will continue to lower premiums across income levels, mitigate financial barriers to care, and sustain enrollment in the marketplaces. Allowing them to expire would reverse these gains, increase the uninsured rate, and raise uncompensated care costs for hospitals and physician practices nationwide. - Opposition to S. 2426, the Equitable Community Access to Pharmacist Services Act (ECAPS) Act. Despite efforts to modify the text of this legislation in the 119th Congress, this bill still has numerous shortcomings, including inappropriately allowing pharmacists to perform services that would normally only be authorized and covered if they were furnished by a physician, testing and treating patients for certain illnesses and expanding Medicare payment for pharmacists in limited but significant ways.

LobbyistCovered position, as disclosed
MICHELLE ROMERO —
CLAYTON STEWART —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 2426 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.